Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSP-130 PK/PD and Safety in Non-metastatic Breast Cancer
NCT02650193Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2015
- Primary completion
- Oct 2017
- Modality
- PEGylated Peptides, Cytokines & Interferons
- Countries
- 2
01
Overview
A Phase 2 trial of pegfilgrastim-apgf in neutropenia, sponsored by Pfizer. Started Dec 2015; status: completed.
02
Drugs
pegfilgrastim-apgf
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT02650193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02650193.